Diagnostic efficacy of brafv600e immunocytochemistry in thyroid aspirates in bethesda category iv and papillary thyroid carcinoma
Background: In papillary thyroid carcinoma (PTC), BRAFV600E is a common mutation and is associated with aggressive clinical behaviour. Immunocytochemistry (ICC) and molecular testing are recommended in the Bethesda System for Reporting Thyroid Cytopathology 2017 (TBSRTC) category III, IV and V. Aims...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Seri Bilgileri: | Journal of Cytology |
| Konular: | |
| Online Erişim: | http://www.jcytol.org/article.asp?issn=0970-9371;year=2021;volume=38;issue=3;spage=113;epage=119;aulast=Anand |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|